The 'Your Friends & Neighbors' actress penned a moving essay for The New Yorker, where she opened up about navigating her own ...

Novartis has struck a front-loaded deal to buy Synnovation Therapeutics’ pan-mutant‑selective PI3Kα inhibitor for $2 billion, ...

Pfizer’s CDK4 inhibitor, atirmociclib, is already being investigated in a Phase III trial as a first-line therapy.

March 17 () - Pfizer said on Tuesday its experimental combination reduced the risk of disease progression ‌or death by 40% in ...

Swiss drugmaker Novartis on Friday agreed to buy a breast cancer drug candidate for up to $3 billion from U.S. biotech firm ...

Gail's Law requires insurance to cover follow-up screenings for women with dense tissue or other high risk factors for breast ...

I had breast cancer in my left breast 14 years ago.

A new study finds AI can potentially detect artery calcification in routine mammograms, helping identify women at risk of ...

Novartis (NVS) has agreed to buy an experimental breast cancer drug from Synnovation Therapeutics for as much as $3B to support its oncology strategy in HR+/HER2- breast cancer. SNV4818 is an oral ...

Suspicious cells build up in mice that haven’t given birth, a new study finds. They could help explain a longstanding mystery ...

Wiles is expected to remain in her post as she undergoes treatment.